241
Views
28
CrossRef citations to date
0
Altmetric
Research Article

P-glycoprotein mediates brain-to-blood efflux transport of buprenorphine across the blood–brain barrier

, , , &
Pages 67-74 | Received 29 Aug 2006, Accepted 28 Nov 2006, Published online: 08 Oct 2008

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

JH. Hu, XD. Liu, L. Xie, GJ. Wang & HY. Liu. (2007) Possible multiple transporters were involved in hepatobiliary excretion of antofloxacin in rats. Xenobiotica 37:6, pages 579-591.
Read now

Articles from other publishers (27)

Xinjian Zhang, Kiyoyuki Kitaichi, Akihiro Mouri, Xinzhu Zhou, Toshitaka Nabeshima, Kiyofumi Yamada & Taku Nagai. (2023) An evaluation method for developing abuse-deterrent opioid formulations with agonist and antagonist combinations using conditioned place preference. Biochemical and Biophysical Research Communications 639, pages 100-105.
Crossref
Flaminia Coluzzi, Maria Sole Scerpa, Monica Rocco & Diego Fornasari. (2022) The Impact of P-Glycoprotein on Opioid Analgesics: What’s the Real Meaning in Pain Management and Palliative Care?. International Journal of Molecular Sciences 23:22, pages 14125.
Crossref
Henriikka Hakomäki, Sophia Eskola, Hannu Kokki, Marko Lehtonen, Juha Räsänen, Sakari Laaksonen, Hanna-Marja Voipio, Veli-Pekka Ranta & Merja Kokki. (2022) Central nervous system distribution of buprenorphine in pregnant sheep, fetuses and newborn lambs after continuous transdermal and single subcutaneous extended-release dosing. European Journal of Pharmaceutical Sciences 178, pages 106283.
Crossref
Alaa M. Hammad, Fawaz Alasmari, Youssef Sari, F. Scott Hall & Amit K. Tiwari. (2018) Alcohol and Cocaine Exposure Modulates ABCB1 and ABCG2 Transporters in Male Alcohol-Preferring Rats. Molecular Neurobiology 56:3, pages 1921-1932.
Crossref
Stephen B. Hladky & Margery A. Barrand. (2018) Elimination of substances from the brain parenchyma: efflux via perivascular pathways and via the blood–brain barrier. Fluids and Barriers of the CNS 15:1.
Crossref
Junzhi Yang, Bianca Reilly, Thomas Davis & Patrick Ronaldson. (2018) Modulation of Opioid Transport at the Blood-Brain Barrier by Altered ATP-Binding Cassette (ABC) Transporter Expression and Activity. Pharmaceutics 10:4, pages 192.
Crossref
Naoto Hashimoto, Noritaka Nakamichi, Erina Yamazaki, Masashi Oikawa, Yusuke Masuo, Alfred H. Schinkel & Yukio Kato. (2017) P-Glycoprotein in skin contributes to transdermal absorption of topical corticosteroids. International Journal of Pharmaceutics 521:1-2, pages 365-373.
Crossref
Robert Gharavi, William Hedrich, Hongbing Wang & Hazem E. Hassan. (2015) Transporter-Mediated Disposition of Opioids: Implications for Clinical Drug Interactions. Pharmaceutical Research.
Crossref
Markus R. Meyer, Lea Wagmann, Nicole Schneider-Daum, Brigitta Loretz, Cristiane de Souza Carvalho, Claus-Michael Lehr & Hans H. Maurer. (2015) P-glycoprotein interactions of novel psychoactive substances – Stimulation of ATP consumption and transport across Caco-2 monolayers. Biochemical Pharmacology 94:3, pages 220-226.
Crossref
Matthew D. Metcalf, Andrew D. Rosicky, Hazem E. Hassan, Natalie D. Eddington, Andrew Coop, Christopher W. Cunningham & Susan L. Mercer. (2014) Opioids and efflux transporters. Part 4: Influence of N-substitution on P-glycoprotein substrate activity of noroxymorphone analogues. Bioorganic & Medicinal Chemistry Letters 24:15, pages 3592-3595.
Crossref
Dan Li, Lei Chen, Youyong Li, Sheng Tian, Huiyong Sun & Tingjun Hou. (2014) ADMET Evaluation in Drug Discovery. 13. Development of in Silico Prediction Models for P-Glycoprotein Substrates . Molecular Pharmaceutics 11:3, pages 716-726.
Crossref
Li Li, Sagar Agarwal & William F. Elmquist. (2013) Brain Efflux Index To Investigate the Influence of Active Efflux on Brain Distribution of Pemetrexed and Methotrexate. Drug Metabolism and Disposition 41:3, pages 659-667.
Crossref
Markus R. Meyer, Tina Orschiedt & Hans H. Maurer. (2013) Michaelis–Menten kinetic analysis of drugs of abuse to estimate their affinity to human P-glycoprotein. Toxicology Letters 217:2, pages 137-142.
Crossref
Bruno Mégarbane & Hisham Alhaddad. (2013) Can P-glycoprotein expression on malignant tumor tissues predict opioid transport at the blood-brain barrier in cancer patients?. Pharmacological Reports 65:1, pages 235-236.
Crossref
Hisham Alhaddad, Salvatore Cisternino, Xavier Declèves, Nicolas Tournier, Joel Schlatter, Fouad Chiadmi, Patricia Risède, Maria Smirnova, Capucine Besengez, Jean-Michel Scherrmann, Frédéric J. Baud & Bruno Mégarbane. (2012) Respiratory toxicity of buprenorphine results from the blockage of P-glycoprotein-mediated efflux of norbuprenorphine at the blood–brain barrier in mice. Critical Care Medicine 40:12, pages 3215-3223.
Crossref
Jun Wang, Bing Cai, Dong-Xiao Huang, Shu-Dong Yang & Lin Guo. (2012) Decreased analgesic effect of morphine, but not buprenorphine, in patients with advanced P-glycoprotein+ cancers. Pharmacological Reports 64:4, pages 870-877.
Crossref
Toyofumi SUZUKI. (2011) Blood-Brain Barrier Transport of Opioid Analgesicsオピオイド鎮痛薬の血液脳関門輸送. YAKUGAKU ZASSHI 131:10, pages 1445-1451.
Crossref
Dhananjay Pal, Deep Kwatra, Mukul Minocha, Durga K. Paturi, Balasubrahmanyam Budda & Ashim K. Mitra. (2011) Efflux transporters- and cytochrome P-450-mediated interactions between drugs of abuse and antiretrovirals. Life Sciences 88:21-22, pages 959-971.
Crossref
Andrea L. Gordon, Olga V. Lopatko, Andrew A. Somogyi, David J. R. Foster & Jason M. White. (2010) (R)- and (S)-methadone and buprenorphine concentration ratios in maternal and umbilical cord plasma following chronic maintenance dosing in pregnancy. British Journal of Clinical Pharmacology 70:6, pages 895-902.
Crossref
Ketan Hippalgaonkar, Ramesh Srirangam, Bharathi Avula, Ikhlas A. Khan & Soumyajit Majumdar. (2010) Interaction between Topically and Systemically Coadministered P-Glycoprotein Substrates/Inhibitors: Effect on Vitreal Kinetics. Drug Metabolism and Disposition 38:10, pages 1790-1797.
Crossref
Nicolas Tournier, Lucie Chevillard, Bruno Megarbane, Stéphane Pirnay, Jean-Michel Scherrmann & Xavier Declèves. (2009) Interaction of drugs of abuse and maintenance treatments with human P-glycoprotein (ABCB1) and breast cancer resistance protein (ABCG2). The International Journal of Neuropsychopharmacology 13:07, pages 905-915.
Crossref
Toyofumi Suzuki, Mariko Miyata, Chika Zaima, Takayuki Furuishi, Toshiro Fukami, Fumihiko Kugawa & Kazuo Tomono. (2010) Blood–brain barrier transport of naloxone does not involve P-glycoprotein-mediated efflux. Journal of Pharmaceutical Sciences 99:1, pages 413-421.
Crossref
Hazem E. Hassan, Alan L. Myers, Andrew Coop & Natalie D. Eddington. (2009) Differential Involvement of P-Glycoprotein (ABCB1) in Permeability, Tissue Distribution, and Antinociceptive Activity of Methadone, Buprenorphine, and Diprenorphine: In Vitro and In Vivo Evaluation. Journal of Pharmaceutical Sciences 98:12, pages 4928-4940.
Crossref
Mark Muzi, David A. Mankoff, Jeanne M. Link, Steve Shoner, Ann C. Collier, Lucy Sasongko & Jashvant D. Unadkat. (2009) Imaging of Cyclosporine Inhibition of P-Glycoprotein Activity Using 11 C-Verapamil in the Brain: Studies of Healthy Humans . Journal of Nuclear Medicine 50:8, pages 1267-1275.
Crossref
Lisa D. Coles, Insong J. Lee, Hazem E. Hassan & Natalie D. Eddington. (2009) Distribution of Saquinavir, Methadone, and Buprenorphine in Maternal Brain, Placenta, and Fetus During Two Different Gestational Stages of Pregnancy in Mice. Journal of Pharmaceutical Sciences 98:8, pages 2832-2846.
Crossref
In Park, Dongwon Kim, Jindeog Song, Chang Hoon In, Seung-Wei Jeong, Sang Hun Lee, Bumchan Min, Dongho Lee & Sun-Ok Kim. (2008) Buprederm™, a New Transdermal Delivery System of Buprenorphine: Pharmacokinetic, Efficacy and Skin Irritancy Studies. Pharmaceutical Research 25:5, pages 1052-1062.
Crossref
Véronique Marguerite, Myléne Beri-Dexheimer, Sandrine Ortiou, Jean-Louis Guéant & Marc Merten. (2007) Cobalamin Potentiates Vinblastine Cytotoxicity Through Downregulation of mdr-1 Gene Expression in HepG2 Cells. Cellular Physiology and Biochemistry 20:6, pages 967-976.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.